Discover investment opportunities in Fertility Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Fertility Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Fertility Stocks using our Smart AI Filter.
7 stocks found for "Fertility Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.64 | ±41.1% | 19.8 | 0.00% | |||
1.40 | ±64.3% | 20.8 | 0.00% | |||
0.82 | ±36.3% | 21.6 | 0.00% | |||
1.49 | ±53.8% | 37.3 | 375.00% | |||
0.36 | ±20.2% | 16.3 | 1.10% | |||
0.37 | ±22.9% | 21.1 | 0.52% | |||
1.77 | ±71.4% | -18.6 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: What makes COHR attractive for growth-focused investors?
A: Coherent Corp. (COHR) operates in the photonics and laser markets, which have high growth potential driven by increasing applications in telecommunications, manufacturing, and healthcare. Historically, companies in this sector benefit from technological advancements and rising demand in innovation-driven industries.
Q: Why do investors looking at healthcare innovation consider TNDM?
A: Tandem Diabetes Care, Inc. (TNDM) is involved in developing technology solutions for diabetes management, a market showing consistent growth due to increasing diabetes prevalence. Their innovation in insulin delivery systems may draw interest from investors focused on the medtech industry's potential expansion.
Q: Is VRTX known for income potential through dividends?
A: Vertex Pharmaceuticals Incorporated (VRTX) does not currently offer dividends, focusing instead on significant R&D investment in cystic fibrosis and other pipelines. Investors interested in sector innovations may find VRTX appealing despite the lack of dividend income.
Q: What are FGEN's primary risks in the current economic environment?
A: FibroGen, Inc. (FGEN) faces risks from regulatory challenges and the high costs associated with biotech research. The ongoing scrutiny in drug approval processes and potential reimbursement issues can impact financial performance. Investors should monitor these factors closely.
Q: How might MYGN benefit or suffer from economic cycles?
A: Myriad Genetics, Inc. (MYGN) operates with a significant portion tied to healthcare diagnostics. Economic downturns can impact discretionary genetic testing spending, while growth phases may boost demand as healthcare spending increases. The cyclical demand can influence MYGN's performance.
Q: Does ICUI have competitive advantages in the medical device market?
A: ICU Medical, Inc. (ICUI) specializes in infusion therapy products, with advantages such as a broad product portfolio and strong hospital relationships. These factors may provide a competitive edge in the medtech space, although sector competition remains intense.